<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 53-year-old female who developed <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) after chemotherapy for adult T-cell <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (ATL) is described </plain></SENT>
<SENT sid="1" pm="."><plain>The latent period of <z:e sem="disease" ids="C1292780" disease_type="Neoplastic Process" abbrv="">therapy-related MDS</z:e> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) from the time of diagnosis of ATL was approximately 35 months </plain></SENT>
<SENT sid="2" pm="."><plain>Cytogenetic analysis of the bone marrow cells at the time of diagnosis of t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> revealed a clonal abnormality; 46,XX,add(7)(p13), der(17)t(3;17)(p11;p13) </plain></SENT>
<SENT sid="3" pm="."><plain>Although monoclonal integration of human T lymphotropic virus type I (HTLV-I) proviral DNA was detected in the peripheral blood lymphocytes at ATL diagnosis, bone marrow cells at t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> diagnosis did not show monoclonal integration of HTLV-I </plain></SENT>
<SENT sid="4" pm="."><plain>To our knowledge, this is the first report of t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> associated with ATL </plain></SENT>
</text></document>